{
    "id": 20016,
    "cites": 3,
    "cited_by": 3,
    "reference": [
        "Aitken ML, Berndt ER, Cutler DM. 2009. Prescription drug spending trends in the United States; looking beyond the turning point. Health Affairs 151. Aitken ML, Berndt ER, Bosworth B, Cockburn IM, Frank RG, Kleinrock M, Shapiro BT. 2013. The regulation of prescription drug competition and market responses: patterns in prices and sales following loss of exclusivity. Cambridge, MA: National Bureau of Economic Research, Working Paper No.",
        "(2):325-30. Frank RG, Salkever DS. 1992. Pricing, patent loss and the market for pharmaceuticals. Southern Economic Journal 59:165-79. Frank RG, Salkever DS. 1997. Generic entry and the pricing of pharmaceuticals. Journal of Economics and Management Strategy. 6(1):75-90. Gatesman M, Smith T. 2011. The Shortage of Essential Chemotherapy Drugs in the United States. New England Journal of Medicine. 365(18):1653-1655. Gaynor MS,Vogt W. 2003. Competition among hospitals. Rand Journal of economics. 34(4):764-85. Conti/Berndt 2014 36 Goldberg P. 2013. Drug Shortages Reach All-Time High\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009dBen Venue Exit Will Make Problem Worse. The Cancer Letter. October 11. Available: http://www.cancerletter.com/articles/20131011. Grabowski H, Long G, Mortimer R. 2011. Implementation of the biosimilar pathway: economic and policy issues. Seton Hall Law Review 41(2):511-557. Grabowski H, Vernon J. 1992. Brand loyalty, entry and price competition in pharmaceuticals after the",
        "Drug Act. Journal of Law and Economics. 35:331-350. Grabowski H, Vernon J. 1996. Longer patents for increased generic competition in the US: the Waxman-Hatch Act after one decade. Pharmacoeconomics 10 Suppl2:110-23. Griliches Z, Cockburn IM. 1994. Generics and new goods in pharmaceutical price indexes. American Economic Review 84(5):1213-32. Huskamp HA, Donohue JM, Koss C, Berndt ER, Frank RF. 2008. Generic Entry, Reformulations and Promotion of SSRIs in the U.S. Pharmacoeconomics. 26:603-616. Iizuka T. 2009. Generic Entry in a Regulated Pharmaceutical Market . Japanese Economic Review."
    ]
}